Emergency Permit for Treatment of Hazardous Waste, Amgen SF, LLC., South San Francisco, California
Summary
SCH Number
2020020578
Public Agency
California Department of Toxic Substances Control
(DTSC)
Document Title
Emergency Permit for Treatment of Hazardous Waste, Amgen SF, LLC., South San Francisco, California
Document Type
NOE - Notice of Exemption
Received
Posted
2/28/2020
Document Description
The California Department of Toxic Substances Control (DTSC), pursuant to authority granted under California Code of Regulations, Title 22, Division 4.5, Chapter 20, Section 66270.61, has issued an Emergency Permit to Amgen SF, LLC., (EPA ID# CAR000143750) to treat hazardous waste through a controlled reaction with a chemical solution. Specifically, one 100-milliliter container of 1,4 dioxane must be stabilized prior to transport to an authorized hazardous waste treatment, storage, and disposal facility. This chemical is currently being stored at Amgen SF, LLC., in South San Francisco, California. DTSC has determined as a safety precaution to prevent an accident or severe injury, an Emergency Permit should be issued to chemically stabilize the hazardous waste prior to storage and eventual transportation off-site by Clean Harbors Environmental Services (CHES).
See NOE for Full Details.
Contact Information
Name
Matthew Mullinax
Agency Name
Department of Toxic Substances Control
Contact Types
Lead/Public Agency
Phone
Name
Agency Name
Simrun Bhul
Contact Types
Project Applicant
Location
Cities
South San Francisco
Counties
San Mateo
Cross Streets
1120 Veterans Boulevard
Notice of Exemption
Exempt Status
Emergency Project
Type, Section or Code
Sec. 21080(b)(4); 15269(b)(c)
Reasons for Exemption
This action is necessary to prevent an emergency. Chemical stabilization of the chemical is necessary prior to transportation to an authorized hazardous waste treatment, storage, and disposal facility to prevent accidental fire and/or explosion during transport
Attachments
Notice of Exemption
Disclaimer: The Governor’s Office of Planning and Research (OPR) accepts no responsibility for the content or accessibility of these documents. To obtain an attachment in a different format, please contact the lead agency at the contact information listed above. For more information, please visit OPR’s Accessibility Site.